Evidence map›Paper›PMID 25169461›Full record

ReviewAcademic pediatrics

Quality concerns in antipsychotic prescribing for youth: a review of treatment guidelines.

Edith Kealey, Sarah Hudson Scholle, Sepheen C Byron, Kimberly Hoagwood, Emily Leckman-Westin, Kelly Kelleher, Molly Finnerty

Abstract readReview
In one paragraph

Review in Academic pediatrics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Trends in Antipsychotic Medication Use in Young Privately Insured Children.Journal of the American Academy of Child and Adolescent Psychiatry · 2021
    Article
  5. Article
  6. Article
  7. Patterns of Antipsychotic Prescribing by Physicians to Young Children.Psychiatric services (Washington, D.C.) · 2016
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Edith KealeyNew York State Office of Mental Health, New York, NY.
Sarah Hudson ScholleNational Committee for Quality Assurance, Washington, DC.
Sepheen C ByronNational Committee for Quality Assurance, Washington, DC.
Kimberly HoagwoodDepartment of Child and Adolescent Psychiatry, New York University School of Medicine, New York, NY.
Emily Leckman-WestinNew York State Office of Mental Health, New York, NY; New York State Office of Mental Health and School of Public Health, State University of New York-Albany, Albany, NY.
Kelly KelleherDepartment of Pediatrics, The Ohio State University College of Medicine and Nationwide Children's Hospital, Columbus, Ohio.
Molly FinnertyNew York State Office of Mental Health, New York, NY; Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York, NY. Electronic address: molly.finnerty@omh.ny.gov.

Funding

Research Methods CoreP30MH090322 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HOAGWOOD, KIMBERLY E. · 2011 to 2015
$8.1M
National Collaborative for Innovation in Quality Measurement (NCINQ)U18HS020503 · AHRQ · NATIONAL COMMITTEE FOR QUALITY ASSURANCE · PI SCHOLLE, SARAH H. · 2011 to 2014
$7.7M
AHRQ HHS U18 HS020503AHRQ HHS U18HS020503NIMH NIH HHS P30 MH090322
6 · The paper itself

Abstract

backgroundAntipsychotic prescribing for youth has increased rapidly, is linked with serious health concerns, and lacks clear measures of quality for pediatric care. We reviewed treatment guidelines relevant to 7 quality concepts for appropriate use and management of youth on antipsychotics: 1) use in very young children, 2) multiple concurrent antipsychotics, 3) higher-than-recommended doses, 4) use without a primary indication, 5) access to psychosocial interventions, 6) metabolic screening, and 7) follow-up visits with a prescriber.

methodsWe searched for clinical practice guidelines meeting the following criteria: developed or endorsed by a national body, published after 2000, and specific treatment recommendations made related to 1 or more of the 7 quality concepts. Sources included electronic databases, the American Academy of Child and Adolescent Psychiatry Web site, and stakeholder and expert advisory committee recommendations. Two raters reviewed the 11 guidelines identified, extracting treatment recommendations, including details that could support measure definitions, and ratings of strength of recommendation and evidence.

resultsAll 7 quality concepts were strongly endorsed by 1 or more guidelines, and 2 or more guidelines assigned their highest strength of recommendation ratings to 6 of the 7 concepts. Two guidelines rated evidence, providing high strength of evidence for 2 quality concepts: psychosocial interventions and metabolic monitoring.

conclusionsGuidelines provide support for 7 quality concepts addressing antipsychotic prescribing for youth. However, guideline support is often based on strong clinical consensus rather than a robust evidence base.

Indexed as

Practice Guidelines as TopicQuality Assurance, Health CareAdolescentAntipsychotic AgentsChildChild, PreschoolHumansInfantPsychotic DisordersUnited StatesAntipsychotic Agentsadolescentsantipsychotic agentschildrenpractice guidelines as topicquality indicators

Identifiers

PMID25169461
PMCPMC4486323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.